<DOC>
	<DOCNO>NCT01221831</DOCNO>
	<brief_summary>This open-label , multi-centre , comparative study young , healthy , female volunteer reproductive age . Primary objective : - To investigate effect 2 dosage estetrol combine P1 P2 , vaginal bleeding pattern ( cycle control ) , comparison combine oral contraceptive contain estradiol valerate dienogest Secondary objective : - To investigate ovulation inhibition - To investigate effect SHBG - To assess pregnancy rate - To evaluate subject satisfaction , dysmenorrhoea , acne , body weight - To investigate return menstruation treatment - To evaluate general safety acceptability</brief_summary>
	<brief_title>Cycle Control Assessment Combined Oral Contraceptive Containing Estetrol Progestin P1 P2</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Women willing use Combined Oral Contraceptive 6 subsequent cycle Good physical mental health Regular menstrual cycle ( 2435 day ) prior screen Body mass index ( ≥ ) 18 ( ≤ ) 30 kg/m2 Previous use hormonal contraceptive method last 3 month prior randomisation ( applicable woman use hormonal contraceptive method time screen ) Previous use progestogenonly contraceptive method last 3 month last 6 month depot progestogen preparation injectable hormonal method contraception Use phytoestrogens No spontaneous menstruation occur follow delivery abortion Breastfeeding within 2 month stop breastfeed prior start study medication spontaneous return menstruation Status postpartum postabortion within period 2 month screen Pregnancy accurate hormonal contraceptive use past Intention become pregnant study An abnormal cervical smear within one year study start Untreated Chlamydia infection Known suspect breast cancer history breast cancer A history ( within 12 month ) alcohol drug abuse Any clinically relevant abnormality Contraindications contraceptive steroid use clinical trial Use antihypertensive drug use medication interact contraceptive steroid use clinical trial Administration investigational drug within 2 month prior screen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>